NFE2L2 and Huntington disease: Although several in vitro studies show a protective effect of Nrf2 activation against Htt-induced toxicity, the activation of the Nrf2 system in striatal cells in response to ROS is disrupted in HD patients due to the concurrent activation of the autophagy pathway [37,88,89,90,91].